Chile, a major global player in critical minerals like copper and lithium, presents a compelling strategic alliance opportunity for India. ...

Indian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...

India and China are set for increased engagement, with New Delhi aiming to strategically leverage its industrial reliance on Beijing. Follo...

Despite India's restrictions on Chinese automakers, their electric vehicle technology is finding its way into the Indian market. Tata Motor...

Despite India's restrictions on Chinese automakers, their electric vehicle technology is finding its way into the Indian market. Tata Motor...

The U.S. Department of Energy is offering $17.5 billion in conditional loans to bolster the domestic nuclear supply chain, aiming to accele...

Niti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...

India expressed cautious optimism regarding the US-Iran understanding and the reopening of the Strait of Hormuz, according to National Secu...

India's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...

India and the US have inked a pact to secure critical mineral supplies, bolstering a broader Quad initiative aiming to invest $20 billion i...

Beijing, a dominant supplier, has retaliated against potential restrictions with export controls. While China attributes its competitivenes...

Aurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...

A new study reveals a significant portion of planned data centers face high climate risks, potentially becoming uninsurable due to extreme ...

The Trump administration is hiring 400 dealmakers to boost US national security supply chains. Top finance professionals will receive salar...

India is poised to gain from global supply chain shifts. Strategic neutrality and domestic focus are key. The nation must build robust buff...

Indian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...

Vietnam, Thailand, and India emerge as key multi-country hubs. AI adoption is high, but integration with compliance platforms is crucial fo...